ARTAS

AI-Integrated Robotic Hair Restoration Revolutionizes Quality Of Life At Dallas Men's Health

Retrieved on: 
Thursday, March 28, 2024
Health, DMH, Patient, Hair loss, ARTAS, Men's Health, Medical device

DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.

Key Points: 
  • DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.
  • The addition of these capabilities unites the 25 years of medical expertise from Dr. Michael Wierschem with the precision of AI-driven, robotic hair restoration solutions.
  • "Adding ARTAS AI-integrated Automated Hair Restoration to our suite of men's wellness services furthers our commitment to comfortably improve men's health and well-being.
  • The novel AI-driven robotic hair restoration service uses minimally-invasive follicle-unit extraction and implantation technology that does not leave a linear scar, promotes comfort, and requires less recovery time than other treatments.

Venus Concept Announces Second Quarter of Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, August 14, 2023
Operating cost, Webcast, International, ARTAS, EBITDA, Marketing, Video game

Total revenue for the second quarter of 2023 decreased $7.2 million, or 26%, to $20.1 million, compared to the second quarter of 2022.

Key Points: 
  • Total revenue for the second quarter of 2023 decreased $7.2 million, or 26%, to $20.1 million, compared to the second quarter of 2022.
  • Gross profit for the second quarter of 2023 decreased $4.8 million, or 25%, to $14.2 million compared to the second quarter of 2022.
  • Operating expenses for the second quarter of 2023 decreased $6.2 million, or 24%, to $20.0 million, compared to the second quarter of 2022.
  • Operating loss for the second quarter of 2023 was $5.8 million, compared to operating loss of $7.1 million for the second quarter of 2022.

Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance

Retrieved on: 
Monday, March 27, 2023
Venus, GAAP, Private placement life insurance, EBITDA, ARTAS, Physician, Indian stock exchange, Artificial intelligence, Growth, Adjustment, Private placement, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Video game, Medical device, Retail

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022.

Key Points: 
  • TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022.
  • Fourth Quarter 2022 Summary & Recent Highlights:
    Total revenue of $24.3 million, down $8.3 million, or 26%, year-over-year; up $2.7 million, or 13% quarter-over-quarter.
  • Cash system revenue represented approximately 71% of total systems and subscriptions revenue, compared to 60% in the prior year period.
  • GAAP net loss attributable to stockholders of $9.9 million, compared to GAAP net loss attributable to stockholders of $4.3 million last year.

Venus Concept Announces the Launch of its latest generation of ARTAS iX, the World’s Most Advanced Robotic Hair Restoration System

Retrieved on: 
Monday, March 20, 2023
Venus, Business, Intelligence, Transplant, American Board of Commissioners for Foreign Missions, ARTAS, Physician, Ix, Artificial intelligence, Growth, Robotics, Software, Medical device

Its latest generation of ARTAS iX sets a new standard for hair transplantation by leveraging cutting-edge robotics, machine vision, artificial intelligence, and machine learning technologies.

Key Points: 
  • Its latest generation of ARTAS iX sets a new standard for hair transplantation by leveraging cutting-edge robotics, machine vision, artificial intelligence, and machine learning technologies.
  • Additional improvements include the new vision system, which improves patient tracking and follicle centering, resulting in better graft quality and enhanced precision.
  • Our enhanced ARTAS iX system marks another major achievement for our Robotics Center of Excellence in its continuous innovation towards revolutionizing hair transplantation.
  • Hair restoration is an important segment for Venus Concept and will continue to be a driver of growth into the future. "

Venus Concept Announces Completion of $6.72 Million Private Placement Financing

Retrieved on: 
Friday, November 18, 2022
Venus, COVID-19, Growth, Private placement, Communication, ARTAS, VWAP, Annual report, Indian stock exchange, Sale, Security (finance), Risk management

TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the Private Placement) of convertible preferred stock (the Preferred Shares) and common stock (the Common Shares) of the Company.

Key Points: 
  • TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the Private Placement) of convertible preferred stock (the Preferred Shares) and common stock (the Common Shares) of the Company.
  • The Common Shares portion of the financing was led by Rajiv De Silva, Chief Executive Officer of Venus Concept, Dr. Hemanth Varghese, President & Chief Business Officer of Venus Concept, and Dr. S. Tyler Hollmig, an independent director of Venus Concept.
  • We appreciate the continued support from our existing investors who participated in this capital raise, said Rajiv De Silva, Chief Executive Officer of Venus Concept.
  • Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.

The "Best in Class" In Unscripted Television Recognized at the 9th Annual American Reality Television Awards (ARTAS), Hosted by Vivica A. Fox

Retrieved on: 
Friday, November 18, 2022
Collective, Android, Criticism, Celebrity Family Feud, Apple TV, Channel, Monsters and Critics, ARTAS, VH1, NFT, Reality television, Roku, Flavor of Love, Celebrity, Partnership, Name, OutSpoken, Gold, Acceptance Speech, AGT, Kimberly Kane, Critic, DJ, News, LOS, Game show, Drama, Reality, BET, Semantic Web, Podcasts (software), IOS, Health, VR, Monster, Social media, Vivica, Amazon, Television, Google Podcasts, Music, Season, Xfinity, American (album), Out TV, FREE, IHeartRadio, Flavor, Internet, Video game, Nightclub, Entertainment, Deezer, Stitcher Radio, Metaverse, Spotify, Love

LOS ANGELES, Nov. 17, 2022 /PRNewswire-PRWeb/ -- The 2022 highest achievers in unscripted television production were just named at the 9th Annual American Reality Television Awards (ARTAS) 9th Annual American Reality Television Awards WINNERS_2022. The 60-minute show, which premiered Thursday, November 17, 2022 at 5PM PT / 8PM ET, was produced in partnership with Reel Mood and celebrated the genre's "best-in-class" across 21 individual categories. Network, cable, streaming shows and reality personalities are eligible every year, with votes collected worldwide, generating millions of votes.

Key Points: 
  • Show is now streaming virtually on OUTtv affiliate platforms, MonstersAndCritics.com and in the Metaverse via Reel Mood
    LOS ANGELES, Nov. 17, 2022 /PRNewswire-PRWeb/ -- The 2022 highest achievers in unscripted television production were just named at the 9th Annual American Reality Television Awards (ARTAS) 9th Annual American Reality Television Awards WINNERS_2022 .
  • Fox ( Vivica A. Fox_ARTAS photos ) virtually and in the Metaverse Vivica at the DJ Booth.PNG .
  • The show named American television personality Tiffany "New York" Pollard ( Tiffany Pollard_Photos ) ( Acceptance Speech ) as the 2022 ARTAS Hall of Fame Award inductee.
  • We celebrated our 9th annual show with some of the biggest names in Reality Television participating.

Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, October 19, 2022
Venus, Securities Act of 1933, Communication, Growth, Employment, Annual report, NASDAQ, Hair, Company, ARTAS, Industry, Securities Exchange Act of 1934, GLOBE, COVID-19, Pharmaceutical industry, Risk management

TORONTO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issueda stock option inducement grant to its President and Chief Business Officer, Hemanth Varghese,upon the effective date of his employment agreement on October 17, 2022.The inducement grant was approved by a majority of the Company's independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement.

Key Points: 
  • TORONTO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issueda stock option inducement grant to its President and Chief Business Officer, Hemanth Varghese,upon the effective date of his employment agreement on October 17, 2022.The inducement grant was approved by a majority of the Company's independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement.
  • The inducement grant was made as a material inducement toDr.
  • It consists of stock options to purchase an aggregate of 1,100,000 shares of the Company's common stock.The inducement grant is subject to the terms and conditions of the award agreement covering the stock option grant.
  • Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.

Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer

Retrieved on: 
Tuesday, October 11, 2022
Bausch & Lomb, Securities Act of 1933, Communication, Therapy, Strategy, Bausch, General manager, Growth, Specialization, Medical physics, Concept, Bausch Health, International Pharmaceutical Students' Federation, Annual report, NASDAQ, Securities Exchange Act of 1934, Ophthalmology, CFA, Corporation, Senior, Hair, Company, ARTAS, Doctor of Philosophy, Industry, Corporate development, GLOBE, Endo International, COVID-19, HLS, Solution, Rajiv, Management, Nightclub, Risk management, Western University

TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Dr. Hemanth Varghese to the position of President & Chief Business Officer, effective October 17, 2022.

Key Points: 
  • TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Dr. Hemanth Varghese to the position of President & Chief Business Officer, effective October 17, 2022.
  • We are delighted to have Hemanth join Venus Concept at this pivotal time for the Company, said Rajiv De Silva, Chief Executive Officer and Director of Venus Concept.
  • Before joining Venus Concept as President and Chief Business Officer, Dr. Varghese served as Senior Vice President of Strategy & Operations at HLS Therapeutics from 2017 to 2022.
  • Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.

Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Thursday, October 6, 2022
Venus, Securities Act of 1933, Communication, Growth, Employment, Annual report, NASDAQ, Hair, Company, ARTAS, Industry, Securities Exchange Act of 1934, GLOBE, COVID-19, Pharmaceutical industry, Risk management

TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issueda stock option inducement grant to its Chief Executive Officer, Rajiv De Silva,upon the execution of his employment agreement on October 2, 2022.The inducement grant was approved by a majority of the Company's independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement.

Key Points: 
  • TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issueda stock option inducement grant to its Chief Executive Officer, Rajiv De Silva,upon the execution of his employment agreement on October 2, 2022.The inducement grant was approved by a majority of the Company's independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement.
  • The inducement grant was made as a material inducement toMr.
  • It consists of stock options to purchase an aggregate of 3,300,000 shares of the Company's common stock.The inducement grant is subject to the terms and conditions of the award agreement covering the stock option grant.
  • Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.

Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results

Retrieved on: 
Wednesday, October 5, 2022
Venus, Webcast, NASDAQ, Hair, Company, ARTAS, GLOBE, Nightclub

TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it is updating the release date for its third quarter of fiscal year 2022 financial results.

Key Points: 
  • TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it is updating the release date for its third quarter of fiscal year 2022 financial results.
  • Third quarter financial results will now be released after the market closes on Thursday, November 10, 2022.
  • Management will host a conference call at 5:00 p.m. Eastern Time on November 10, 2022 to discuss the results of the quarter with a question and answer session.
  • Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD.